Advertisement

Adenosine A2 Receptor Regulation of Striatal Gene Expression

  • Serge N. Schiffmann
  • Jean-Jacques Vanderhaeghen

Abstract

Any perturbations within the basal ganglia system lead to movement disorders [1]. The striatum, receiving its main input from the cerebral cortex, is the first relay of this system, and its medium-sized spiny neurons give rise to the output pathways. Two subpopulations of these efferent GABAergic neurons have been identified. The neurons projecting to the globus pallidus, striatopallidal, express enkephalin and mostly the dopamine D2 receptor, whereas the neurons projecting to the susbtantia nigra pars reticulata, striatonigral, express substance P, dynorphin, and the dopamine D1 receptor [2]. These two subpopulations give rise to different loops, acting respectively as an inhibitory and an excitatory pathway to the thalamus [1]. In addition, two classes of interneurons mostly represent the remaining striatal neurons: the cholinergic and the somatostatin-expressing neurons.

Keywords

Dopamine Depletion Caffeine Treatment Dopaminergic Nigrostriatal Pathway Basal Ganglion System Striatopallidal Neuron 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Albin RL, Young AB, Penney B (1989) The functional anatomy of basal ganglia disorders. Trends Neurosci 12:366–375.PubMedCrossRefGoogle Scholar
  2. 2.
    Gerfen CR, Engber TM, Mahan LC, Susel Z, Chase, TN, Monsma FJ Jr, Sibley DR (1990) Dl and D2 dopamine receptor-regulated gene expression of striatonigral and striatopallidal neurons. Science 250:1429–1432.PubMedCrossRefGoogle Scholar
  3. 3.
    Schiffmann SN, Libert F, Vassart G, Dumont JE, Vanderhaeghen JJ (1990) A cloned G protein-coupled protein with a distribution restricted to striatal medium sized neurons. Possible relationship with D1 dopamine receptor. Brain Res 519:333–337.PubMedCrossRefGoogle Scholar
  4. 4.
    Schiffmann SN, Jacobs O, Vanderhaeghen JJ (1991a) The striatal restricted adenosine A2 receptor (RDC8) is expressed by enkephalin but not by substance P neurons. An in situ hybridization histochemistry study. J Neurochem 57:1062–1067.CrossRefGoogle Scholar
  5. 5.
    Schiffmann SN, Libert F, Vassart G, Vanderhaeghen JJ (1991) Distribution of adenosine A2 receptor mRNA in the human brain. Neurosci Lett 130:177–181.PubMedCrossRefGoogle Scholar
  6. 6.
    Schiffmann SN, Vanderhaeghen J-J (1993) Adenosine A2 receptors regulate the gene expression of striatopallidal and striatonigral neurons. J Neurosci 13:1080–1087.PubMedGoogle Scholar
  7. 7.
    Vanderhaeghen et al., present book.Google Scholar
  8. 8.
    Fink JS, Weaver DR, Rivkees SA, Peterfreund RA, Pollack AE, Adler EM, Reppert SM (1992) Molecular cloning of the rat A2 adenosine receptor: Selective co-expression with D2 dopamine receptors in rat striatum. Mol Brain Res 14:186–195.PubMedCrossRefGoogle Scholar
  9. 9.
    Augood SJ, Emson PC (1994) Adenosine A2a receptor mRNA is expressed by enkephalin cells but not by somatostatin cells in rat striatum: A co-expressin study. Mol Brain Res 22:204–210.PubMedCrossRefGoogle Scholar
  10. 10.
    Durcan MJ, Morgan PF (1989) Evidence for adenosine A2 receptor involvement in the hypomobility effects of adenosine analogues in mice. Eur J Pharmacol 168:285–290.PubMedCrossRefGoogle Scholar
  11. 11.
    Ferre S, Herrera-Marschitz M, Grabowska-Anden M, Ungerstedt U, Casas M, Anden N-E (1991) Postsynaptic dopamine/adenosine interaction: I. Adenosine analogues inhibit dopamine D2-mediated behaviour in short-term reserpinized mice. Eur J Pharmacol 192:25–30.PubMedCrossRefGoogle Scholar
  12. 12.
    Ferre S, Herrera-Marschitz M, Grabowska-Anden M, Casas M, Ungerstedt U, Anden N-E (1991) Postsynaptic dopamine/adenosine interaction: II. Post-synaptic dopamine agonism and adenosine antagonism of methylxanthines in short-term reserpinized mice. Eur J Pharmacol 192:31–37.PubMedCrossRefGoogle Scholar
  13. 13.
    Jarvis MF, Williams M (1987) Adenosine and dopamine function in the CNS. Trends Pharmacol Sci 8:330–331.CrossRefGoogle Scholar
  14. 14.
    Ferre S, Von Euler G, Johanson B, Fredholm BB, Fuxe K (1991) Stimulation of adenosine A2 receptors decreases the affinity of dopamine D2 receptors in rat striatal membranes. Proc Natl Acad Sci USA 88:7238–7241.PubMedCrossRefGoogle Scholar
  15. 15.
    Fuxe et al., present book.Google Scholar
  16. 16.
    Ferre S, O’Connor WT, Fuxe K, Ungerstedt U (1993) The striatopallidal neuron: A main locus for adenosine-dopamine interactions in the brain. J Neurosci 13:5402–5406.PubMedGoogle Scholar
  17. 17.
    Mayfield RD, Suzuki F, Zahniser N (1993) Adenosine A2a receptor modulation of electrically evoked endogenous GABA release from slices of rat globus pallidus. J Neurochem 60: 2334–2337.PubMedCrossRefGoogle Scholar
  18. 18.
    Bergman H, Wichmann T, DeLong MR (1990) Reversal of experimental parkinsonism by lesions of the subthalamic nucleus. Science 249:1436–1438.PubMedCrossRefGoogle Scholar
  19. 19.
    Schiffmann SN, Vanderhaeghen J-J (1993b) Caffeine regulates neurotensin and cholecystokinin messenger RNA expression in the rat striatum. Neuroscience 54:681–689.CrossRefGoogle Scholar
  20. 20.
    Schiffmann SN, Vanderhaeghen JJ (1992) Lesion of the nigrostriatal pathway induces cholecystokinin mRNA expression in the rat striatum. An in situ hybridization histochemistry study. Neuroscience 50:551–558.PubMedCrossRefGoogle Scholar
  21. 21.
    Merchant KM, Dobner PR, Dorsa DM (1992) Differential effects of haloperidol and clozapine on neurotensin gene transcription in rat neostriatum. J Neurosci 12:652–663.PubMedGoogle Scholar
  22. 22.
    Onali P, Olianas MC, Bunse B (1988) Evidence that adenosine A2 and dopamine autoreceptors antagonistically regulate tyrosine hydroxylase activity in rat striatal synaptosomes. Brain Res 456:302–309.PubMedCrossRefGoogle Scholar
  23. 23.
    Zetterström T, Fillenz M (1990) Adenosine agonists can both inhibit and enhance in vivo striatal dopamine release. Eur J Pharmacol 180:137–143.PubMedCrossRefGoogle Scholar
  24. 24.
    Johanson B, Lindström K, Fredholm BB (1994) Differences in the regional and cellular localization of c-fos messenger RNA induced by amphetamine, cocaine and caffeine in the rat. Neuroscience 59:837–849.CrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media New York 1995

Authors and Affiliations

  • Serge N. Schiffmann
  • Jean-Jacques Vanderhaeghen

There are no affiliations available

Personalised recommendations